# Topical Infliximab for Sterile Corneal Melt

> **NCT02987686** · PHASE1 · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 7 (actual)

## Conditions studied

- Sterile Corneal Melt

## Interventions

- **DRUG:** Topical Infliximab

## Key facts

- **NCT ID:** NCT02987686
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-06
- **Primary completion:** 2025-11-15
- **Final completion:** 2025-11-15
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02987686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02987686, "Topical Infliximab for Sterile Corneal Melt". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02987686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*